Agilent Technologies Company Profile (NYSE:A)

Agilent Technologies trades on the New York Stock Exchange (NYSE) under the ticker symbol "A."

Agilent Technologies announced a quarterly dividend on Wednesday, May 17th. Investors of record on Monday, July 3rd will be paid a dividend of $0.132 per share on Wednesday, July 26th. This represents a $0.53 dividend on an annualized basis and a yield of 0.87%. The ex-dividend date is Thursday, June 29th. View Agilent Technologies' Dividend History.

Agilent Technologies, Inc. (NYSE:A) announced its quarterly earnings results on Tuesday, August, 15th. The company reported $0.59 earnings per share for the quarter, topping the consensus estimate of $0.52 by $0.07. The business earned $1.11 billion during the quarter, compared to analysts' expectations of $1.09 billion. Agilent Technologies had a net margin of 14.36% and a return on equity of 17.25%. Agilent Technologies's quarterly revenue was up 6.7% on a year-over-year basis. During the same period in the prior year, the company posted $0.49 earnings per share. View Agilent Technologies' Earnings History.

Agilent Technologies updated its fourth quarter earnings guidance on Tuesday, August, 15th. The company provided earnings per share (EPS) guidance of $0.60-0.62 for the period, compared to the Thomson Reuters consensus earnings per share estimate of $0.60. The company issued revenue guidance of $1.15-1.17 billion, compared to the consensus revenue estimate of $1.15 billion.

14 brokers have issued 1-year price targets for Agilent Technologies' stock. Their forecasts range from $53.00 to $70.00. On average, they expect Agilent Technologies' stock price to reach $63.41 in the next twelve months. View Analyst Ratings for Agilent Technologies.

Here are some recent quotes from research analysts about Agilent Technologies stock:

• 1. According to Zacks Investment Research, "Agilent Technologies is a broad-based OEM of test and measurement equipment. The company’s fiscal first quarter results were above the Zacks Consensus estimate. Over the last one year, the stock has underperformed the Zacks Electronic-Testing Equipment Industry. The company’s decision to divest/wind up underperforming businesses has enhanced its focus on the new Agilent, while enabling expansion of a solid recurring revenue base and diversification of geographic and industrial operations for growth. Also, the company’s focus on aligning investments so as to be oriented toward more attractive growth avenues and innovative high-margin product launches are positives. Agilent’s broad-based portfolio and increased focus on segments offer higher growth potential. However, the macro weakness in the U.S. and Europe and forex headwinds remain concerns." (5/16/2017)
• 2. UBS AG analysts commented, "Agilent reported FY1Q17 results Tuesday with sales of $1.067b, above both ours and consensus estimates of $1.05b. Adj. EPS of $0.53 was also above both ours estimate of $0.50 and consensus estimates of $0.49. For FY17 management slightly lowered its revenue guidance to $4.33 - $4.35b from $4.35b - $4.37b, but increased the midpoint of its core growth guidance to 4.5% from 4.3%. Agilent maintained its FY17 adjusted EPS guidance to $2.10 - $2.16." (2/15/2017)

Some companies that are related to Agilent Technologies include Boston Scientific Corporation (BSX), Intuitive Surgical (ISRG), Koninklijke Philips N.V. (PHG), Illumina (ILMN), Edwards Lifesciences Corporation (EW), Cerner Corporation (CERN), Waters Corporation (WAT), Hologic (HOLX), ResMed (RMD), Varian Medical Systems (VAR), PerkinElmer (PKI), ABIOMED (ABMD), Bruker Corporation (BRKR), Alere (ALR), Accelerate Diagnostics (AXDX), Natus Medical Incorporated (BABY), Quidel Corporation (QDEL) and ABAXIS (ABAX).

Agilent Technologies' management team includes the folowing people:

• Michael R. McMullen, President, Chief Executive Officer, Director
• Didier Hirsch, Chief Financial Officer, Senior Vice President
• Michael Tang, Senior Vice President, General Counsel, Secretary
• Dominique P. Grau, Senior Vice President - Human Resources
• Henrik Ancher-Jensen, Senior Vice President, President - Order Fulfillment
• Mark Doak, Senior Vice President, President - Agilent CrossLab Group
• Patrick K. Kaltenbach, Senior Vice President, President - Life Sciences and Applied Markets Group
• Samraat Raha, Senior Vice President - Strategy and Corporate Development
• Jacob Thaysen, Senior Vice President, President - Diagnostics and Genomics Group
• Rodney Gonsalves, Chief Accounting Officer, Vice President, Corporate Controller

Agilent Technologies' stock is owned by a variety of of retail and institutional investors. Top institutional shareholders include BlackRock Inc. (7.28%), Vanguard Group Inc. (6.88%), FMR LLC (6.13%), State Street Corp (4.45%), JPMorgan Chase & Co. (3.78%) and State Farm Mutual Automobile Insurance Co. (2.15%). Company insiders that own Agilent Technologies stock include Boon Hwee Koh, Didier Hirsch, Dominique Grau, Heidi Fields, James Cullen, Mark Doak, Michael R Mcmullen, Patrick Kaltenbach, Paul N Clark, Robert J Herbold and Rodney Gonsalves. View Institutional Ownership Trends for Agilent Technologies.

Agilent Technologies' stock was sold by a variety of institutional investors in the last quarter, including FMR LLC, Balyasny Asset Management LLC, BNP Paribas Arbitrage SA, Victory Capital Management Inc., TIAA CREF Investment Management LLC, Cantillon Capital Management LLC, Cambiar Investors LLC and Russell Investments Group Ltd.. Company insiders that have sold Agilent Technologies stock in the last year include Boon Hwee Koh, Didier Hirsch, Dominique Grau, Heidi Fields, James Cullen, Mark Doak, Michael R Mcmullen, Patrick Kaltenbach, Paul N Clark and Rodney Gonsalves. View Insider Buying and Selling for Agilent Technologies.

Agilent Technologies' stock was bought by a variety of institutional investors in the last quarter, including JPMorgan Chase & Co., PNC Financial Services Group Inc., Los Angeles Capital Management & Equity Research Inc., Voya Investment Management LLC, Janus Henderson Group PLC, WCM Investment Management CA, Vanguard Group Inc. and Koch Industries Inc.. View Insider Buying and Selling for Agilent Technologies.

Shares of Agilent Technologies can be purchased through any online brokerage account. Popular online brokerages include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Scottrade, Fidelity and Charles Schwab.

One share of Agilent Technologies stock can currently be purchased for approximately $60.86.